https://www.templehealth.org/services/lung/research-clinical-trials/study-evaluating-safety-and-efficacy-of-ap01-in-participants-with-progressive-pulmonary-fibrosis
A randomized, double-blind, placebo-controlled clinical study to evaluate the safety and efficacy of 2 doses of AP01 versus placebo on top of standard of care in participants with PPF over 52 weeks.
https://www.tuj.ac.jp/
Temple University, Japan Campus is the oldest and largest American University in Japan. About 60% of undergraduate students are from overseas. Enjoy campus life 100% in Tokyo while earning American associate's, bachelor's, master's or doctoral degrees.
https://www.templehealth.org/about/news/in-the-media/dr-meghan-musselman-joins-fox29s-good-day-philadelphia-for-live-interview-on-brain-rot
Dr. Meghan Musselman participated in an interview on FOX29’s “Good Day Philadelphia” about “brain rot,” or overuse of digital devices and the negative cognitive and psychiatric effects.
https://www.templehealth.org/about/news/in-the-media/dwight-mcbee-describes-temples-patient-centered-approach-to-care
Dwight McBee, Chief Experience Officer at Temple University Health System, spoke to PhillyVoice for an article on compassionate care. McBee described CiCARE, Temple’s effort to promote compassion, teamwork and communication among employees and staff, as well as with patients. He detailed two recent moments where members put CiCARE into action.